| Taylor Mahanna, MSOT, OTR/L | |
|
131 W Grace St, Harrisonburg, VA 22807-9158 | |
| (540) 568-4980 | |
| Not Available |
| Full Name | Taylor Mahanna |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 131 W Grace St, Harrisonburg, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205430683 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 0119-008864 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Taylor Mahanna, MSOT, OTR/L 541 Harbour Place Ct, Lexington, SC 29072-9020 Ph: () - | Taylor Mahanna, MSOT, OTR/L 131 W Grace St, Harrisonburg, VA 22807-9158 Ph: (540) 568-4980 |
News Archive
This year, the Miami Beach symposium kicked off on a rainy Friday with a new name and a new focus on biomarkers. For seven years, the meeting has been called the Mild Cognitive Impairment Symposium, but that changed this year to the Symposium on Early Alzheimer's Disease. The change comes as a nod to a recent and dramatic shift in how Alzheimer disease is perceived, and what researchers increasingly see as the most promising angle of attack for future therapeutics.
A team of researchers at Cold Spring Harbor Laboratory (CSHL) has identified a leukemia-specific stretch of DNA called an enhancer element that enables cancerous blood cells to proliferate in Acute Myeloid Leukemia (AML), a devastating cancer that is incurable in 70% of patients.
Shire plc, the global specialty biopharmaceutical company, announces that its subsidiary Shire Pharmaceuticals Inc. received a ruling from the FDA on its Citizen's Petition relating to Pentasa.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it has entered into a Cooperative Research and Development Agreement with the National Cancer Institute's (NCI) Cancer Therapy Evaluation Program (CTEP) to collaborate on the conduct of a randomized Phase 2 trial of ZYBRESTAT in combination with bevacizumab in patients with relapsed ovarian cancer.
In its latest pioneering effort to harness the power of focused ultrasound to battle disease, the University of Virginia Health System is examining the scalpel-free surgery's potential to enable the body to identify and destroy metastatic breast cancer cells.
› Verified 9 days ago
Therese Barnhart Leigh, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Court Sq, Harrisonburg, VA 22802 Phone: 540-434-2752 | |
Elizabeth E. Richardson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 131 W. Grace St., Rm 1100, Harrisonburg, VA 22807 Phone: 540-568-4980 | |
Katie Anne Chapman Smith, OTR/L Occupational Therapist Medicare: May Accept Medicare Assignments Practice Location: 1481 Virginia Ave, Harrisonburg, VA 22802 Phone: 540-437-4315 | |
Shannon Kibler, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2101 Deyerle Ave, Harrisonburg, VA 22801 Phone: 540-765-1539 | |
Mrs. Amy Beth Mitchem, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1501 Virginia Ave, Harrisonburg, VA 22802 Phone: 540-564-3400 | |
Julie Jenkins, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 463 E Washington St, Harrisonburg, VA 22802 Phone: 540-434-1941 | |
Melissa Rodriguez, MS, OT/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2101 Deyerle Ave, Harrisonburg, VA 22801 Phone: 540-432-0409 |